Yuexun Xu1, Hui Luo2, Qunchao Hu2, Haiyan Zhu2. 1. Department of Gynecology and Obstetrics, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China. 2. Department of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China.
Abstract
Background: Cervical cancer became the third most common cancer among women, and genome characterization of cervical cancer patients has revealed the extensive complexity of molecular alterations. However, identifying driver mutation and depicting molecular classification in cervical cancer remain a challenge. Methods: We performed an integrative multi-platform analysis of a cervical cancer cohort from The Cancer Genome Atlas (TCGA) based on 284 clinical cases and identified the driver genes and possible molecular classification of cervical cancer. Results: Multi-platform integration showed that cervical cancer exhibited a wide range of mutation. The top 10 mutated genes were TTN, PIK3CA, MUC4, KMT2C, MUC16, KMT2D, SYNE1, FLG, DST, and EP300, with a mutation rate from 12 to 33%. Applying GISTIC to detect copy number variation (CNV), the most frequent chromosome arm-level CNVs included losses in 4p, 11p, and 11q and gains in 20q, 3q, and 1q. Then, we performed unsupervised consensus clustering of tumor CNV profiles and methylation profiles and detected four statistically significant expression subtypes. Finally, by combining the multidimensional datasets, we identified 10 potential driver genes, including GPR107, CHRNA5, ZBTB20, Rb1, NCAPH2, SCA1, SLC25A5, RBPMS, DDX3X, and H2BFM. Conclusions: This comprehensive analysis described the genetic characteristic of cervical cancer and identified novel driver genes in cervical cancer. These results provide insight into developing precision treatment in cervical cancer.
Background: Cervical cancer became the third most common cancer among women, and genome characterization of cervical cancerpatients has revealed the extensive complexity of molecular alterations. However, identifying driver mutation and depicting molecular classification in cervical cancer remain a challenge. Methods: We performed an integrative multi-platform analysis of a cervical cancer cohort from The Cancer Genome Atlas (TCGA) based on 284 clinical cases and identified the driver genes and possible molecular classification of cervical cancer. Results: Multi-platform integration showed that cervical cancer exhibited a wide range of mutation. The top 10 mutated genes were TTN, PIK3CA, MUC4, KMT2C, MUC16, KMT2D, SYNE1, FLG, DST, and EP300, with a mutation rate from 12 to 33%. Applying GISTIC to detect copy number variation (CNV), the most frequent chromosome arm-level CNVs included losses in 4p, 11p, and 11q and gains in 20q, 3q, and 1q. Then, we performed unsupervised consensus clustering of tumor CNV profiles and methylation profiles and detected four statistically significant expression subtypes. Finally, by combining the multidimensional datasets, we identified 10 potential driver genes, including GPR107, CHRNA5, ZBTB20, Rb1, NCAPH2, SCA1, SLC25A5, RBPMS, DDX3X, and H2BFM. Conclusions: This comprehensive analysis described the genetic characteristic of cervical cancer and identified novel driver genes in cervical cancer. These results provide insight into developing precision treatment in cervical cancer.
Authors: Xingyu Cheng; Han Yin; Juan Fu; Chunya Chen; Jianhong An; Jiexia Guan; Rong Duan; Hengming Li; Hong Shen Journal: J Cancer Res Clin Oncol Date: 2019-02-27 Impact factor: 4.553
Authors: Peter Bager; Jan Wohlfahrt; Erik Sørensen; Henrik Ullum; Claus Kim Høgdall; Connie Palle; Lise Lotte Nystrup Husemoen; Allan Linneberg; Susanne K Kjaer; Mads Melbye; Jacob P Thyssen Journal: Acta Oncol Date: 2014-11-10 Impact factor: 4.089
Authors: Dan Chen; Ivana Juko-Pecirep; Joanna Hammer; Emma Ivansson; Stefan Enroth; Inger Gustavsson; Lars Feuk; Patrik K E Magnusson; James D McKay; Erik Wilander; Ulf Gyllensten Journal: J Natl Cancer Inst Date: 2013-03-12 Impact factor: 13.506
Authors: Pulivarthi H Rao; Hugo Arias-Pulido; Xin-Yan Lu; Charles P Harris; Hernan Vargas; Fang F Zhang; Gopeshwar Narayan; Achim Schneider; Mary Beth Terry; Vundavalli V V S Murty Journal: BMC Cancer Date: 2004-02-06 Impact factor: 4.430
Authors: Xiangchun Li; Weiqi Xu; Wei Kang; Sunny H Wong; Mengyao Wang; Yong Zhou; Xiaodong Fang; Xiuqing Zhang; Huanming Yang; Chi H Wong; Ka F To; Stephen L Chan; Matthew T V Chan; Joseph J Y Sung; William K K Wu; Jun Yu Journal: Theranostics Date: 2018-02-12 Impact factor: 11.556
Authors: Pravrutha Raman; Mary C Rominger; Janet M Young; Antoine Molaro; Toshio Tsukiyama; Harmit S Malik Journal: Mol Biol Evol Date: 2022-02-03 Impact factor: 16.240